Human PDS5B/APRIN/AS3 ORF/cDNA clone-Mammalian (Non-Viral Vector) plasmid (NM_015032.3)

Cat. No.: pGMPC000012
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human PDS5B/APRIN/AS3 Non-Viral expression plasmid (overexpression vector) for mouse PDS5B overexpression in unique cell transient transfection and stable cell line development.


Purchase
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMPC000012
Gene Name PDS5B
Accession Number NM_015032.3
Gene ID 23047
Species Human
Product Type Mammalian (Non-Viral Vector) plasmid (overexpression)
Insert Length 4344 bp
Gene Alias APRIN,AS3,CG008
Fluorescent Reporter EGFP
Mammalian Cell Selection Null
Fusion Tag Null
Promoter EF1
Resistance Amplicin
ORF Nucleotide Sequence ATGGCTCATTCAAAGACTAGGACCAATGATGGAAAAATTACATATCCGCCTGGGGTCAAGGAAATATCAGATAAAATATCTAAAGAGGAGATGGTGAGACGATTAAAGATGGTTGTGAAAACTTTTATGGATATGGACCAGGACTCTGAAGAAGAAAAGGAGCTTTATTTAAACCTAGCTTTACATCTTGCTTCAGATTTTTTTCTCAAGCATCCTGATAAAGATGTTCGCTTACTGGTAGCCTGCTGCCTTGCTGATATTTTCAGGATTTATGCTCCTGAAGCTCCTTACACATCCCCTGATAAACTAAAGGATATATTTATGTTTATAACAAGACAGTTGAAGGGGCTAGAGGATACAAAGAGCCCACAATTCAATAGGTATTTTTATTTACTTGAGAACATTGCTTGGGTCAAGTCATATAACATATGCTTTGAGTTAGAAGATAGCAATGAAATTTTCACCCAGCTATACAGAACCTTATTTTCAGTTATAAACAATGGCCACAATCAGAAAGTCCATATGCACATGGTAGACCTTATGAGCTCTATTATTTGTGAAGGTGATACAGTGTCTCAGGAGCTTTTGGATACGGTTTTAGTAAATCTGGTACCTGCTCATAAGAATTTAAACAAGCAAGCATATGATTTGGCAAAGGCTTTACTGAAGAGGACAGCTCAAGCTATTGAGCCATATATTACCAATTTTTTTAATCAGGTTCTGATGCTTGGGAAAACATCTATCAGCGATTTGTCAGAGCATGTCTTTGACTTAATTTTGGAGCTCTACAATATTGATAGTCATTTGCTGCTCTCTGTTTTACCCCAGCTTGAATTTAAATTAAAGAGCAATGATAATGAGGAGCGCCTACAAGTTGTTAAACTACTGGCAAAAATGTTTGGGGCAAAGGATTCAGAATTGGCTTCTCAAAACAAGCCACTTTGGCAGTGCTACTTGGGCAGGTTTAATGATATCCATGTACCAATCCGCCTGGAATGTGTGAAATTTGCTAGCCATTGTCTCATGAACCATCCTGATTTAGCAAAAGACTTAACAGAGTATCTTAAAGTGAGGTCACATGACCCTGAGGAAGCTATTAGACATGATGTTATTGTGTCAATAGTTACAGCTGCTAAAAAGGATATTCTTCTGGTCAATGATCACTTACTTAATTTTGTGAGAGAGAGAACATTAGACAAACGATGGAGAGTACGCAAAGAAGCCATGATGGGACTTGCCCAAATTTATAAGAAATATGCTTTACAGTCAGCAGCTGGAAAAGATGCTGCAAAACAGATAGCATGGATCAAAGACAAATTGCTACATATATATTATCAAAATAGTATTGATGATCGACTACTTGTTGAACGGATCTTTGCTCAATACATGGTTCCTCACAATTTAGAAACTACAGAACGGATGAAATGCTTATATTACTTGTATGCCACACTGGATTTAAATGCTGTGAAAGCATTGAATGAAATGTGGAAATGTCAAAATCTGCTCCGACATCAAGTAAAGGATTTGCTTGACTTGATTAAGCAACCCAAAACAGATGCCAGTGTCAAGGCCATATTTTCAAAAGTGATGGTTATTACAAGAAATTTACCTGATCCTGGTAAGGCTCAGGATTTCATGAAGAAATTCACACAGGTGTTAGAAGATGATGAGAAAATAAGAAAGCAGTTAGAAGTACTTGTTAGTCCAACATGCTCCTGCAAGCAGGCTGAAGGTTGTGTGCGTGAAATAACTAAGAAGTTGGGCAACCCCAAACAGCCTACAAATCCTTTCCTGGAAATGATCAAGTTTCTCTTGGAGAGGATAGCACCTGTGCACATAGATACCGAATCTATCAGTGCTCTTATTAAACAAGTGAACAAATCAATAGATGGAACAGCAGATGATGAAGATGAGGGTGTTCCAACTGATCAAGCCATCAGAGCAGGTCTTGAACTGCTTAAGGTACTCTCATTTACACATCCCATCTCATTTCATTCTGCTGAAACATTTGAATCATTACTGGCTTGTCTGAAAATGGATGATGAAAAAGTAGCAGAAGCTGCACTACAAATTTTCAAAAACACAGGAAGCAAAATTGAAGAGGATTTTCCACACATCAGATCAGCCTTGCTTCCTGTTTTACATCACAAATCTAAAAAAGGACCCCCCCGTCAAGCCAAATATGCCATTCATTGTATCCATGCGATATTTTCTAGTAAAGAGACCCAGTTTGCACAGATATTTGAGCCTCTGCATAAGAGCCTAGATCCAAGCAACCTGGAACATCTCATAACACCATTGGTTACTATTGGTCATATTGCTCTCCTTGCACCTGATCAATTTGCTGCTCCTTTGAAATCTTTGGTAGCTACTTTCATTGTGAAAGATCTTCTCATGAATGATCGGCTTCCAGGGAAAAAGACAACTAAACTTTGGGTTCCAGATGAAGAAGTATCTCCTGAGACAATGGTCAAAATTCAGGCTATTAAAATGATGGTTCGATGGCTACTTGGAATGAAAAATAATCACAGTAAATCAGGAACTTCTACCTTAAGATTGCTAACAACAATATTGCATAGTGATGGAGACTTGACAGAACAGGGGAAAATTAGTAAACCAGATATGTCACGTCTGAGACTTGCTGCTGGGAGTGCTATTGTGAAGCTGGCACAAGAACCCTGTTACCATGAAATCATCACATTAGAACAATATCAGCTATGTGCATTAGCTATCAACGATGAATGCTATCAAGTAAGACAAGTGTTTGCCCAGAAACTTCACAAAGGCCTTTCCCGTTTACGGCTTCCACTTGAGTATATGGCAATCTGTGCCCTTTGTGCAAAAGATCCTGTAAAGGAGAGAAGAGCTCATGCTAGGCAATGTTTGGTGAAAAATATAAATGTAAGGCGGGAGTATCTGAAGCAGCATGCAGCTGTTAGTGAAAAATTATTGTCTCTTCTACCAGAGTATGTTGTTCCATATACAATTCACCTTTTGGCACATGACCCAGATTATGTCAAAGTACAGGATATTGAACAACTTAAAGATGTTAAAGAATGTCTTTGGTTTGTTCTGGAAATATTAATGGCTAAAAATGAAAATAACAGTCACGCTTTTATCAGAAAGATGGTAGAAAATATTAAACAAACAAAAGATGCCCAAGGACCAGATGATGCAAAAATGAATGAAAAACTGTACACTGTGTGTGATGTTGCCATGAATATCATCATGTCAAAGAGTACTACATACAGTTTGGAATCTCCTAAAGACCCGGTACTACCAGCTCGTTTCTTCACTCAACCTGACAAGAATTTCAGTAACACCAAAAATTATCTGCCTCCTGAAATGAAATCATTTTTCACTCCTGGAAAACCTAAAACAACCAATGTTCTAGGAGCTGTTAACAAGCCACTTTCATCAGCAGGCAAGCAATCTCAGACCAAATCATCACGAATGGAAACTGTAAGCAATGCAAGCAGCAGCTCAAATCCAAGCTCTCCTGGAAGAATAAAGGGGAGGCTTGATAGTTCTGAAATGGATCACAGTGAAAATGAAGATTACACAATGTCTTCACCTTTGCCGGGGAAAAAAAGTGACAAGAGAGACGACTCTGATCTTGTAAGGTCTGAATTGGAGAAGCCTAGAGGCAGGAAAAAAACGCCCGTCACAGAACAGGAGGAGAAATTAGGTATGGATGACTTGACTAAGTTGGTACAGGAACAGAAACCTAAAGGCAGTCAGCGAAGTCGGAAAAGAGGCCATACGGCTTCAGAATCTGATGAACAGCAGTGGCCTGAGGAAAAGAGGCTCAAAGAAGATATATTAGAAAATGAAGATGAACAGAATAGTCCGCCAAAAAAGGGTAAAAGAGGCCGACCACCAAAACCTCTTGGTGGAGGTACACCAAAAGAAGAGCCAACAATGAAAACTTCTAAAAAAGGAAGCAAAAAAAAATCTGGACCTCCAGCACCAGAGGAGGAGGAAGAAGAAGAAAGACAAAGTGGAAATACGGAACAGAAGTCCAAAAGCAAACAGCACCGAGTGTCAAGGAGAGCACAGCAGAGAGCAGAATCTCCTGAATCTAGTGCAATTGAATCCACACAGTCCACACCACAGAAAGGACGAGGAAGACCATCAAAAACGCCATCACCATCACAACCAAAAAAAAATGTCCGTGTAGGACGCTCCAAACAAGCAGCTACTAAGGAAAATGATTCAAGTGAAGAAGTAGATGTGTTTCAGGGTAGCTCTCCTGTCGATGATATTCCACAGGAAGAAACAGAGGAGGAGGAAGTTTCTACAGTAAATGTACGGCGGCGAAGTGCTAAAAGGGAACGGCGATGA
ORF Protein Sequence MAHSKTRTNDGKITYPPGVKEISDKISKEEMVRRLKMVVKTFMDMDQDSEEEKELYLNLALHLASDFFLKHPDKDVRLLVACCLADIFRIYAPEAPYTSPDKLKDIFMFITRQLKGLEDTKSPQFNRYFYLLENIAWVKSYNICFELEDSNEIFTQLYRTLFSVINNGHNQKVHMHMVDLMSSIICEGDTVSQELLDTVLVNLVPAHKNLNKQAYDLAKALLKRTAQAIEPYITNFFNQVLMLGKTSISDLSEHVFDLILELYNIDSHLLLSVLPQLEFKLKSNDNEERLQVVKLLAKMFGAKDSELASQNKPLWQCYLGRFNDIHVPIRLECVKFASHCLMNHPDLAKDLTEYLKVRSHDPEEAIRHDVIVSIVTAAKKDILLVNDHLLNFVRERTLDKRWRVRKEAMMGLAQIYKKYALQSAAGKDAAKQIAWIKDKLLHIYYQNSIDDRLLVERIFAQYMVPHNLETTERMKCLYYLYATLDLNAVKALNEMWKCQNLLRHQVKDLLDLIKQPKTDASVKAIFSKVMVITRNLPDPGKAQDFMKKFTQVLEDDEKIRKQLEVLVSPTCSCKQAEGCVREITKKLGNPKQPTNPFLEMIKFLLERIAPVHIDTESISALIKQVNKSIDGTADDEDEGVPTDQAIRAGLELLKVLSFTHPISFHSAETFESLLACLKMDDEKVAEAALQIFKNTGSKIEEDFPHIRSALLPVLHHKSKKGPPRQAKYAIHCIHAIFSSKETQFAQIFEPLHKSLDPSNLEHLITPLVTIGHIALLAPDQFAAPLKSLVATFIVKDLLMNDRLPGKKTTKLWVPDEEVSPETMVKIQAIKMMVRWLLGMKNNHSKSGTSTLRLLTTILHSDGDLTEQGKISKPDMSRLRLAAGSAIVKLAQEPCYHEIITLEQYQLCALAINDECYQVRQVFAQKLHKGLSRLRLPLEYMAICALCAKDPVKERRAHARQCLVKNINVRREYLKQHAAVSEKLLSLLPEYVVPYTIHLLAHDPDYVKVQDIEQLKDVKECLWFVLEILMAKNENNSHAFIRKMVENIKQTKDAQGPDDAKMNEKLYTVCDVAMNIIMSKSTTYSLESPKDPVLPARFFTQPDKNFSNTKNYLPPEMKSFFTPGKPKTTNVLGAVNKPLSSAGKQSQTKSSRMETVSNASSSSNPSSPGRIKGRLDSSEMDHSENEDYTMSSPLPGKKSDKRDDSDLVRSELEKPRGRKKTPVTEQEEKLGMDDLTKLVQEQKPKGSQRSRKRGHTASESDEQQWPEEKRLKEDILENEDEQNSPPKKGKRGRPPKPLGGGTPKEEPTMKTSKKGSKKKSGPPAPEEEEEEERQSGNTEQKSKSKQHRVSRRAQQRAESPESSAIESTQSTPQKGRGRPSKTPSPSQPKKNVRVGRSKQAATKENDSSEEVDVFQGSSPVDDIPQEETEEEEVSTVNVRRRSAKRERR

Reference




    Data / case study


    Click to get more Data / Case study about the product.







    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.